Results 201 to 210 of about 1,105,809 (304)

Implementing exercise interventions in pediatric oncology: an expert consensus framework from the FORTEe project. [PDF]

Front Oncol
Neu MA, Dreismickenbecker E, Wypyrsczyk L, Spreafico F, Balduzzi A, Heißerer B, Marriott H, Paul NW, Watson E, Bloch W, Fridh MK, Götte M, Kitanovski L, Konda B, Lucia A, Mongondry R, Rizvi K, Larsen HB, Bauer N, Beller R, Fiuza-Luces C, Gauß G, Kühn M, Moriggi TP, Pérol O, Olivier F, Ravnik D, Rovan M, Santana-Sosa E, Stefanović M, Wright P, Zardo W, Lanfranconi F, Wiskemann J, Faber J.   +34 more
europepmc   +1 more source

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

British Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay, Amandine Manon, Hunter Stephens, S. Y. Amy Cheung, Bart de Keizer, Erik T. te Beek   +5 more
wiley   +1 more source

Sleep and psychiatric problems in pediatric oncology patients: A case-control study. [PDF]

Sleep Breath
Sahin S, Ozdilekcan C, Hamurcu HD, Ozlugedik S, Kaymak M, Bayhan T, Sarı N, Ilhan IE.   +7 more
europepmc   +1 more source

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

British Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Acute Pancreatitis Complicating L-asparaginase Therapy in Pediatric Oncology: A Case Report. [PDF]

Cureus
Larda L, Ryouni K, Kawtar E, Mounia EA, Benajiba N.   +4 more
europepmc   +1 more source

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

British Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher, Amina Džidić‐Krivić, Emma Pinjic, Nejra Selak, Kanita Omerbasic, Alexandar Chupin, Andrej Belancic, Almir Fajkic   +7 more
wiley   +1 more source

Optimizing the Efficacy-Toxicity Paradigm in Pediatric Oncology: A Narrative Review of Immunotherapy and Survivorship Outcomes. [PDF]

Curr Oncol
Dushimova Z, Saliev T, Bazarbayeva A, Karimova K, Kussainov A, Fakhradiyev I.   +5 more
europepmc   +1 more source

Cation Enrichment and Hypersialylation in Chronic Rhinosinusitis Mucus

International Forum of Allergy &Rhinology, EarlyView.
Amanda M. Wood, Rachel E. Detwiler, McKenna Coughlin, Chelsea E. Pollard, Jeremiah A. Alt, Abigail Pulsipher, Jessica Kramer Stratton   +6 more
wiley   +1 more source

From anthelmintic to neuro‐oncology: A systematic review of mebendazole repurposing for brain tumour therapy

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Mebendazole (MBZ), a benzimidazole anthelmintic with established clinical use, has emerged as a repurposing candidate for primary brain tumours due to its multimodal anticancer actions and central nervous system penetrance. This systematic review synthesizes preclinical and clinical evidence evaluating MBZ's efficacy, mechanisms of action ...
Ciara B. Blum, Milli McMenamin, Tessa Khoo, John M. Edwin, Prathibha Jose, Liam A. O’Callaghan   +5 more
wiley   +1 more source